Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment. A phase I, open-label, single-dose, three-centre study.
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2015
At a glance
- Drugs Telavancin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 02 Nov 2015 New trial record